Previous Article | Next Article 
Journal of Virology, December 2000, p. 11099-11107, Vol. 74, No. 23
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Murine Cytomegalovirus Containing a Mutation at
Open Reading Frame M37 Is Severely Attenuated in Growth and
Virulence In Vivo
Manfred
Lee,
Jianqiao
Xiao,
Erik
Haghjoo,
Xiaoyan
Zhan,
Gerry
Abenes,
Tong
Tuong,
Walter
Dunn, and
Fenyong
Liu*
Program in Infectious Diseases and Immunity,
School of Public Health, University of California, Berkeley,
California 94720
Received 14 July 2000/Accepted 5 September 2000
 |
ABSTRACT |
A pool of murine cytomegalovirus (MCMV) mutants was generated by
using a Tn3-based transposon mutagenesis procedure. One of the mutants, RvM37, which contained the transposon sequence at open
reading frame M37, was characterized both in tissue culture and in
immunocompetent BALB/c and immunodeficient SCID mice. Our results
provide the first direct evidence to suggest that M37 is not essential
for viral replication in vitro in NIH 3T3 cells. Compared to the
wild-type strain and a rescued virus that restored the M37 region, the
viral mutant was severely attenuated in growth in both BALB/c and SCID
mice after intraperitoneal infection. Specifically, titers of the Smith
strain and rescued virus in the salivary glands, lungs, spleens,
livers, and kidneys of the SCID mice at 21 days postinfection were
about 5 × 105, 2 × 105, 5 × 104, 5 × 103, and 1 × 104 PFU/ml of organ homogenate, respectively; in contrast,
titers of RvM37 in these organs were less than 102 PFU/ml
of organ homogenate. Moreover, the virulence of the mutant virus
appeared to be significantly attenuated because none of the SCID mice
infected with RvM37 had died by 120 days postinfection, while all
animals infected with the wild-type and rescued viruses had died by 26 days postinfection. Our results suggest that M37 probably encodes a
virulence factor and is required for MCMV virulence in SCID mice and
for optimal viral growth in vivo.
 |
INTRODUCTION |
Human cytomegalovirus (HCMV) is a
ubiquitous herpesvirus that typically causes asymptomatic infections in
healthy individuals but may lead to serious complications in newborns
and immunodeficient individuals (4, 32). Like other
herpesviruses, HCMV causes acute infection that progresses to
persistence and latency followed by periodic reactivation. Its 230-kb
DNA genome is the largest among all human herpesviruses and has the
capacity to encode more than 220 open reading frames, in contrast to
only about 85 open reading frames for herpes simplex virus type 1 (7, 30, 32, 39). Unlike the well-studied herpes simplex and
Epstein-Barr viruses, HCMV is a betaherpesvirus that propagates only in
human cells and grows very slowly due to its long lytic replication cycle (4, 32). There is currently no suitable animal model available for studying HCMV infection in vivo. The functions of many
gene products encoded by HCMV in viral pathogenesis, virulence, and
latency have not been studied. Consequently, related viruses, such as
murine CMV (MCMV), must be used to investigate the tissue tropism,
virulence, latency, and reactivation of HCMV (21, 24, 32).
MCMV has proved a useful model for CMV disease. MCMV also causes acute,
latent, and persistent infections of the natural hosts (21, 24,
32). MCMV pathogenesis closely resembles that of HCMV, and both
viruses cause severe infections in the immunocompromised or
immunologically immature hosts, resulting in similar clinical syndromes. Moreover, analysis of the complete nucleotide sequence of
MCMV (Smith strain) has revealed that more than 75 open reading frames
have significant sequence homology to those of HCMV (7, 37).
These findings have further provided evidence to support the observed
biological similarities between these two viruses. In vivo studies of
the functions of the genes encoded by MCMV, especially those that are
highly conserved with those encoded by HCMV, should allow us to
investigate the mechanism of viral pathogenesis and, furthermore,
provide insight into the functions of their HCMV counterparts in viral
infections in humans.
One of the most powerful approaches to identify the function of
virus-encoded genes is to introduce mutations into the viral genome and
to screen viral mutants in both tissue culture and animals for possible
growth defects in vitro and in vivo. The construction of herpesvirus
mutants via site-directed homologous recombination and
transposon-mediated insertional mutagenesis has been reported (5,
22, 42, 51). Methods using overlapping cosmid DNA fragments to
generate mutants of HCMV and other herpesviruses have also been
reported (8, 13, 25, 47, 48). More recently, the MCMV genome
as well as the genomes of other herpesviruses were cloned into a
bacterial artificial chromosome (BAC), and MCMV mutants were
successfully generated from the BAC-based viral genome by both
site-directed homologous recombination and transposon-mediated insertional mutagenesis (5, 15, 31, 41-43, 45, 50). The
BAC-based mutagenesis approach provides a powerful and convenient strategy to generate viral mutants and facilitates studies of the
functions of viral genes in tissue culture and in animals.
Many of the CMV genes have been found to be dispensable for growth in
cultured cells. Their presence in the viral genome indicates that they
are probably needed to perform functions involved only in modulating
the viral interactions with the respective human or animal hosts. For
example, HCMV US2, a nonessential protein, functions to prevent antigen
presentation of both major histocompatibility complex class I and II
pathways (23, 46). Meanwhile, MCMV open reading frame m131,
which encodes a
-chemokine homologue and is dispensable for viral
replication in vitro, functions as a determinant for viral
pathogenecity and appears to promote monocyte-associated viremia and
dissemination of the virus in vivo (16, 27, 28, 40). Thus,
studies of viral mutants carrying mutations in genes found to be
dispensable in tissue culture are valuable for understanding the
function of the genes in viral pathogenesis and virus-host interactions.
We have previously generated a pool of MCMV mutants using a
Tn3 transposon-mediated shuttle mutagenesis system (53,
54). In this approach, the transposon is randomly inserted into
the MCMV genomic DNA fragments in a plasmid library in
Escherichia coli. Regions bearing an insertion mutation are
then transferred to the MCMV genome by cotransfecting the plasmid
library and purified MCMV genomic DNA into NIH 3T3 cells. In the
present study, we have characterized an MCMV mutant, RvM37, which
contains a transposon insertion in open reading frame M37, a homologue
of HCMV UL37 open reading frame (7, 37). The products coded
by UL37 are immediate-early membrane proteins localized in mitochondria
as well as in the plasma membrane (1, 11, 12). The UL37
proteins have been shown to selectively transactivate the expression of genes under control of both cellular and HCMV promoters (10, 12). More recently, these proteins have also been implicated to
have antiapoptotic activities (17). However, the function of
UL37 as well as M37 in vivo in viral replication and pathogenesis is
not known. Indeed, to our knowledge, the M37 open reading frame has not
been characterized transcriptionally or translationally. Our results
provide the first direct evidence to suggest that M37 is not essential
for viral replication in vitro in tissue culture. When the viruses were
used to infect immunocompetent BALB/c mice and immunodeficient SCID
mice intraperitoneally, titers of the viral mutant in the salivary
glands, lungs, spleens, livers, and kidneys were significantly lower
than those of the wild-type virus and a revertant virus that rescued
the mutation and restored the M37 open reading frame. Moreover, the
viral mutant is avirulent in SCID mice. These results provide the first
direct evidence to suggest that M37 may encode a viral virulence factor
required for killing SCID mice and for optimal viral growth in vivo.
 |
MATERIALS AND METHODS |
Cells and viruses.
Mouse NIH 3T3 and STO cells and the
wild-type Smith strain of MCMV were purchased from the American Type
Culture Collection, Manassas, Va. Cells were maintained in Dulbecco's
modified Eagle medium (DMEM) supplemented with 10% NuSerum (Becton
Dickinson, Bedford, Mass.), essential and nonessential amino acids, and
penicillin-streptomycin (each from a stock solution purchased from Life
Technologies Inc. [Gibco BRL, Grand Island, N.Y.]) (53).
The wild-type Smith strain, mutant RvM37, and the revertant virus RqM37
were propagated in NIH 3T3 cells as described previously
(53).
Analysis of growth of viruses in vitro.
Growth kinetics of
the wild-type virus, mutant RvM37, and rescued virus RqM37 were
determined as described previously (54). Briefly, NIH 3T3
cells grown to 50 to 60% confluence were inoculated with virus at a
multiplicity of infection (MOI) of either 0.5 or 5. At 0, 1, 2, 4, and
7 days postinfection, the infected cells together with medium were
harvested, and an equal volume of 10% skim milk was added before
sonication. Virus titers were determined by plaque assays in NIH 3T3
cells; the values reported are averages from triplicate experiments.
Virulence assays.
Virulence of the viruses was determined on
the basis of mortality of the animals infected with the Smith strain,
RvM37, or RqM37. CB17 SCID mice (National Cancer Institute, Bethesda,
Md.) (five animals per group) were infected intraperitoneally with 104 PFU of each virus. The animals were observed twice
daily; mortality of infected animals was monitored for at least 120 days postinfection, and survival rates were determined.
Construction of an MCMV DNA subclone pool, transposon-based
shuttle mutagenesis, and generation of MCMV recombinant mutants and
rescued viruses.
Isolation of viral genomic DNA, construction of a
MCMV genomic subclone pool, and transposon-based shuttle mutagenesis to generate a pool of MCMV DNA fragments containing a transposon insertion
were performed as described by Zhan et al. (53). To generate
a pool of MCMV mutants that contained the transposon sequence,
full-length MCMV genomic DNA and plasmid DNA containing MCMV fragments
were cotransfected into NIH 3T3 cells by a calcium phosphate
precipitation protocol (Gibco BRL). The recombinant MCMV was selected
in the presence of mycophenolic acid (25 µg/ml; Gibco BRL) and
xanthine (50 µg/ml; Sigma, St. Louis, Mo.) and plaque purified six
times as described by Zhan et al. (53). To confirm
integration of the transposon in the viral genome and identify the
genes that contained the transposon insertion, viral DNA was purified
and directly sequenced using the primer FL110PRIM (5'-GCAGGATCCTATCCATATGAC-3') and an fmol cycle sequencing
kit (Promega, Inc., Madison, Wis.).
To construct the rescued virus RqM37, the full-length genomic DNA of
RvM37 was isolated from virus-infected cells as described previously
(53). The DNA sequence that contained the coding sequence of
M37 was generated by PCR using MCMV genomic DNA as the template and the
5' primer M37-sense (5'-ACCTGGAGTGGCACTTGCCG-3') and the 3'
primer M37-antisense (5'-CGCGAGCCTCTGTATCGATA-3'). The PCR
product that contained the M37 coding sequence (1 to 3 µg) and the
full-length intact RvM37 viral genomic DNA (8 to 12 µg) were
subsequently cotransfected into mouse STO fibroblasts by using a
calcium phosphate precipitation protocol (Gibco BRL). The recombinant
virus was selected in the presence of 6-thioguanine (25 µg/ml; Sigma)
and purified by six rounds of amplification and plaque purification as
described previously (18). For each cotransfection, several
viral plaques were picked and expanded. Viral stocks were prepared by
growing the viruses in T-150 flasks of NIH 3T3 cells.
Analysis of growth of viruses in animals.
Four-week-old male
BALB/c-Byj mice (Jackson Laboratory, Bar Harbor, Maine) or 6-week-old
CB17 SCID mice (National Cancer Institute) were infected
intraperitoneally with 104 PFU of each virus. The animals
were sacrificed at 1, 3, 7, 10, 14, and 21 days postinoculation.
Salivary glands were also collected from the BALB/c mice at 28 days
postinfection. For each time point, at least three animals were used as
a group and infected with the same virus. The salivary glands, lungs,
spleens, livers, and kidneys were harvested and sonicated as a 10%
(wt/vol) suspension in a 1:1 mixture of DMEM and 10% skim milk. The
sonicates were stored at
80°C until plaque assays were performed.
Viruses harvested from the mice were titered on NIH 3T3 cells in
six-well tissue culture plates (Corning Inc., Corning, N.Y.).
Briefly,
cells were first infected with the viruses at 10-fold
serial dilutions.
After 90 min of incubation with the homogenates
diluted in 1 ml of
complete medium at 37°C, the cells were overlaid
with fresh complete
medium containing 1% agarose and cultured
for 4 to 5 days before the
plaques were counted. Viral titers
(recorded as PFU per milliliter of
organ homogenate) for each
sample were determined in triplicate. The
limit of virus detection
in the organ homogenates was 10 PFU/ml of the
sonicated mixture.
Those samples that were negative at a
10
1 dilution were assigned a titer value of 10 (10
1) PFU/ml.
Southern and Northern analyses of recombinant viruses.
Viral
genomic DNA was purified from NIH 3T3 cells infected with the viruses
as described previously (49, 53). Briefly, cells that
exhibited 100% cytopathic effect were washed with phosphate-buffered saline and then lysed with a solution that contained sodium dodecyl sulfate and proteinase K. The genomic DNA was purified by extraction with phenol-chloroform followed by precipitation with 2-propanol. The
DNA was then digested with HindIII or EcoRI,
separated on agarose gels (0.8%), transferred to Zeta-Probe nylon
membranes (Bio-Rad, Hercules, Calif.), and hybridized with
32P-labeled DNA probes that are specific for both the
transposon and MCMV sequences. A STORM 840 PhosphorImager was used to
analyze the blots.
For Northern blot analysis, cells were infected with virus at an MOI of
5 and harvested at different time points postinfection.
Total
cytoplasmic RNA was isolated from NIH 3T3 cells infected
with the
viruses as described previously (
26). Viral RNAs were
separated in a 1% agarose gel that contained formaldehyde, transferred
to a nitrocellulose membrane, hybridized with the
32P-radiolabeled DNA probes that contained the MCMV
sequences, and
finally analyzed with a STORM 840 PhosphorImager. The
DNA probes
used for Northern analyses were generated by PCR using viral
DNA
as the template and radiolabeled with a random primer synthesis
kit
in the presence of [
32P]dCTP (Boehringer Mannheim,
Indianapolis, Ind.). The 5' and 3'
PCR primers used to construct the
DNA probe for the transcript
in the M37 region were M37-5'NDS
(5'-AAATCACACCGAGACGGTGC-3')
and M37-3'NDS
(5'-ATCTTTGAACAGCGACTCGC-3'), respectively. The
5' and 3'
PCR primers used to construct the DNA probe for transcripts
in the M25
region were M25-5'NDS (5'-CGACGACGATGACGACGATG-3')
and
M25-3'NDS (5'-GTCCTGACCGCTCACTACAC-3'),
respectively.
 |
RESULTS |
Construction of an MCMV mutant with the transposon
insertion at open reading frame M37.
Using an E. coli
Tn3-based transposon mutagenesis system, we recently
constructed a pool of MCMV mutants carrying random insertions of the
transposon sequence (53). Figure
1A shows the structure of the transposon
used to generate MCMV mutants. The transposon, designated
Tn3-gpt, contains the expression cassette encoding guanine
phosphoribosyltransferase (gpt) and an additional
transcription termination site, which allow selection of MCMV mutants
in mammalian cells and transcription termination of the target gene at
the insertion site, respectively (53). The direction of
transcription of the gpt expression cassette is opposite
that of the additional poly(A) signal (Fig. 1A). Such a design should
ensure undisrupted expression of nearby genes that may share a poly(A)
signal with the targeted gene.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Schematic representation of the structure of the
transposon construct used for mutagenesis. TR, terminal repeat; Tet,
tetracycline resistance gene; poly(A), transcription termination
signal. (B) Location of the transposon insertion in the recombinant
virus. The transposon sequence is shown as a filled bar; the coding
sequence of open reading frame M37 is represented by an open arrow. The
orientation of the arrow represents the direction of the translation
and transcription predicted based on the nucleotide sequence
(37); numbers represent sizes of the DNA fragments of the
viruses that were generated by digestion with HindIII
(H) or EcoRI (E). WT, wild type. (C) Southern analyses of
recombinant viruses. DNA samples (20 µg) isolated from cells infected
with the wild-type (WT) virus, RvM37, or RqM37 were digested with
either HindIII (H) or EcoRI (E), separated on
0.8% agarose gels, transferred to a Zeta-Probe membrane, and
hybridized to a DNA probe (the plasmid that contained the MCMV DNA
fragment inserted with the transposon sequence).
|
|
To generate a pool of MCMV mutants containing a transposon sequence, an
MCMV genomic library containing a randomly inserted
transposon in each
fragment was first created by using a shuttle
mutagenesis method as
described by Zhan et al. (
53). Such a
library of
Tn
3-gpt-MCMV fragments were then cotransfected with
the
full-length genomic DNA of the wild-type virus (Smith strain)
into
mouse NIH 3T3 cells. Homologous recombination between the
full-length
Smith strain viral DNA and the DNA fragments inserted
with the
Tn
3-gpt transposon sequence occurs in the transfected
NIH
3T3 cells. Cells that contained the recombinant viruses would
express
the
gpt protein and were allowed to grow in culture medium
containing mycophenolic acid and xanthine. Under these conditions,
only
the viruses expressing the
gpt protein were selected
(
18,
33,
49). After multiple rounds of selection and plaque
purification,
we isolated individual recombinant viruses and determined
the
location of the inserted transposon by directly sequencing the
genomic DNA of the recombinants. One of the recombinant viruses
that
were further characterized is reported here. This viral mutant,
designated RvM37, contains the transposon sequence inserted within
open
reading frame M37 (Fig.
1B). Sequence analyses of the junction
between
the transposon and the viral sequence revealed that the
transposon in
RvM37 is located at nucleotide position 50104 (amino
acid residue 125 of the 345-amino-acid-long open reading frame)
with reference to the
genome sequence of the wild-type Smith strain
(
37) (Fig.
1B
and data not
shown).
Characterization of the genomic structure of viral mutant RvM37 and
rescued virus RqM37.
Southern blot hybridization analysis was
carried out to examine the genomic structure of RvM37 and to map the
location of the transposon insertion in the viral genome, using a DNA
probe containing both the transposon and viral sequences (Fig. 1B and C). A small fragment of 1.8 kb representing the gpt gene was
detected when the viral DNA samples were digested with
HindIII and subjected to Southern analyses. This
observation indicates the presence of the transposon sequence within
the viral genome (Fig. 1C, lane 3). This finding was further supported
by the results of Southern analyses of the RvM37 DNA samples digested
with another restriction enzyme, EcoRI (Fig. 1C, lane 6). In
these experiments, the genomic fragments containing the transposon were
shown to be 3.6 kb larger than the wild-type virus, which is the size
of the transposon (Fig. 1B and C).
The Southern blots also showed that stocks of the mutant virus were
pure and free of the wild-type strain, as hybridizing
DNA fragments
from the mutant did not comigrate with those of
the wild-type Smith
strain (Fig.
1C, lanes 1, 3, 4, and 6). For
example, the hybridization
patterns of the RvM37 and Smith strain
DNAs digested with
HindIII gave rise to DNA bands of 14.4, 13.9,
and 1.8 kb
and a single DNA band of 26.3 kb, respectively (Fig.
1C, lanes 1 and
3). Meanwhile, the hybridized species (16.6 kb)
of the
EcoRI-digested RvM37 DNA migrated differently from that
(13 kb) of the wild-type viral DNA digested with the same enzyme
(Fig.
1C,
lanes 4 and 6). The sizes of the hybridized DNA fragments
(Fig.
1C)
were consistent with the predicted digestion patterns
of the
recombinant virus, based on the MCMV genomic sequence (
37)
and the location of the transposon insertion in the viral genome
as
determined by sequence analysis (Fig.
1B). The restriction
enzyme
digestion patterns of the regions of the RvM37 genomic
DNAs other than
the transposon insertional site appeared to be
identical to those of
the parental Smith strain, as indicated
by ethidium bromide staining of
the digested DNAs (data not shown).
This observation suggested that
regions of the viral genome other
than that containing the transposon
insertion remained intact
in this MCMV
mutant.
To restore the M37 open reading frame, a rescued virus, designated
RqM37, was derived from RvM37 via a protocol similar to
that used for
construction of the viral mutants. A DNA fragment
that contained the
M37 coding region was cotransfected with the
full-length RvM37 genomic
DNA into mouse STO cells. Homologous
recombination between the
full-length RvM37 viral DNA and the
DNA fragment containing the M37
coding sequence would occur in
the transfected cells. The cells that
harbored the progeny viruses
were allowed to grow in the presence of
6-thioguanine, which selects
against
gpt expression
(
18,
33). The rescued virus, RqM37,
which did not express
the
gpt protein and no longer contained
the transposon, was
isolated after multiple rounds of selection
and plaque
purification.
To determine whether the M37 region was restored in RqM37, the genomic
structure of the rescued virus was studied by Southern
hybridization
analyses using DNA probes containing the transposon
and the viral
sequence (Fig.
1C). Analysis of the RqM37 DNA samples
digested with
HindIII and
EcoRI showed that the sizes of
the hybridized
DNA fragments for RqM37 were identical to those of the
hybridized
fragments for the Smith strain and different from those for
RvM37.
These results indicate that RqM37 did not contain the transposon
sequence and the M37 region was restored (Fig.
1C, lanes 2 and
5).
Moreover, the restriction enzyme digestion patterns of the
regions of
the rescued RqM37 genomic DNA samples other than the
M37 region
appeared to be identical to those of the parental RvM37,
as indicated
by ethidium bromide staining of the digested DNAs
(data not shown).
These observations suggest that regions of the
RqM37 genome other the
M37 region remained intact and identical
to those of RvM37. Thus, RqM37
may represent a rescued virus for
RvM37.
Characterization of transcription from the MCMV M37 region in
tissue culture.
Whether there is transcription from the M37 open
reading frame has not been reported. Transcription from the target M37
region is expected to be disrupted due to the presence of the two
transcription termination signals within the transposon (Fig. 1A). In
particular, the region of the M37 open reading frame downstream from
the transposon insertion site is not expected to be expressed. To
determine whether this is the case, cytoplasmic RNAs were isolated from
cells infected with the mutant virus at different time points (e.g., 4, 12, and 24 h) postinfection. Northern analysis was carried out to
detect expression of the transcripts from the M37 open reading frame downstream from the transposon insertion site (Fig.
2). The probe used in the Northern
analyses contained the DNA sequence complementary to the M37 coding
region about 100 nucleotides downstream from the site of the transposon
insertion. An abundant RNA species of about 4 kb was detected in the
RNA fractions isolated from cells that were infected with the wild-type
Smith strain (Fig. 2, lane 2). However, this transcript was not
detected in the RNA fractions isolated from cells infected with RvM37
when the same probe was used (Fig. 2, lane 3). Meanwhile, expression of
the transcript was found in the RNA fractions from cells infected with
the rescued virus RqM37 (Fig. 2, lane 4). The level of MCMV M25
transcript (14, 52, 53) was used as the internal control for
expression of the M37 transcript. As shown in Fig. 2 (lanes 5 to 8),
substantial amounts of the M25 transcript were detected in cells that
were infected with RvM37, RqM37, and the Smith strain (Fig. 2, lanes 5 to 8). Thus, the transposon insertion in RvM37 disrupted the transcript
expressed from the M37 open reading frame, whereas expression of the
transcript was restored in RqM37. A probe from the 3' end of the M37
open reading frame sequence was also used in the Northern analysis.
With this probe, the M37 transcript of ~4 kb was readily detected in
cells infected with the Smith strain and RqM37. However, the M37
transcript was not detected in cells infected with RvM37. These results
further support our conclusion that the region of the M37 open reading
frame downstream from the transposon insertion site is not expressed.

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 2.
Northern analyses of RNA fractions isolated from cells
that were mock infected (lanes 1 and 5) or infected with the wild-type
virus (WT; lanes 2 and 6), RvM37 (lanes 3 and 7), and RqM37 (lanes 4 and 8). NIH 3T3 cells (107) were infected with each virus
at an MOI of 5 PFU per cell and harvested at 24 h postinfection.
RNA samples (20 to 30 µg) were separated on agarose gels that
contained formaldehyde, transferred to a nitrocellulose membrane, and
hybridized to a 32P-radiolabeled probe that contained the
sequence of M37 (lanes 1 to 4) or M25 (lanes 5 to 8). Sizes are
indicated in kilobase pairs.
|
|
Characterization of growth of viruses in vitro in tissue
culture.
To determine whether the recombinant viruses RvM37 and
RqM37 have any growth defects in vitro, NIH 3T3 cells were infected with these viruses at both low and high MOIs. Growth rates of the
viruses in mouse NIH 3T3 cells were assayed and compared to those of
the parental Smith strain. The results, obtained from triplicate
experiments (Fig. 3), indicate that no
significant difference was found in growth rates among RvM37, RqM37,
and the Smith strain. For example, the peak titers of RvM37 and RqM37 were similar to that of the parental Smith strain (Fig. 3). These results, combined with those from the Southern and Northern analyses, suggest that M37 is not essential for viral growth in tissue culture.

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 3.
In vitro growth of MCMV mutants in tissue culture. Mouse
NIH 3T3 cells were infected with each virus at an MOI of 0.5 (A) or 5 (B) PFU per cell. At 0, 1, 2, 4, and 7 days postinfection, cells and
culture media were harvested and sonicated. Viral titers were
determined by plaque assays on NIH 3T3 cells; the values shown
represent averages from triplicate experiments; standard deviations are
indicated by the error bars. WT, wild type.
|
|
Characterization of growth of viruses in immunocompetent
animals.
To determine whether disruption of M37 significantly
affects viral growth in vivo, BALB/c-Byj mice were injected
intraperitoneally with 104 PFU of RvM37, RqM37, or the
wild-type Smith strain. At 1, 3, 7, 10, 14, and 21 days postinfection,
salivary glands, lungs, spleens, livers, and kidneys were harvested,
and viral titers from these five organs were determined on NIH 3T3
cells (Fig. 4). The titers of viruses
from the salivary glands at 28 days postinfection were also determined
(Fig. 4A). These organs are among the major targets for MCMV infection
(4, 21, 24, 32). At days 14 and 21 postinfection, the titers
of RvM37 found in the salivary glands were about 200- and 2,000-fold,
respectively, lower than those of the Smith strain (Fig. 4A). Moreover,
the titers of RvM37 found in the lungs, spleens, livers, and kidneys of
the infected animals at 10 days postinfection were at least 10-fold
lower than the titers of the Smith strain found in the same organs from
the infected animals (Fig. 4B to E). In contrast, the titers of the
rescued virus RqM37 found in these organs were similar to the titers of
the Smith strain. Previous studies have shown that the presence of the
transposon sequence per se within the viral genome does not
significantly affect viral growth in mice in vivo (54).
Thus, these results suggest that the attenuated growth of RvM37 is due
to the disruption of M37 and that open reading frame M37 is important
for MCMV growth in these five organs in vivo in BALB/c mice.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 4.
Titers of MCMV mutants in salivary glands, lungs,
spleens, livers, and kidneys of infected BALB/c mice. BALB/c-Byj mice
were infected intraperitoneally with 104 PFU of each virus.
At 1, 3, 7, 10, 14, and 21 days postinfection, the animals (three mice
per group) were sacrificed. The salivary glands, lungs, spleens,
livers, and kidneys were collected and sonicated. The salivary glands
were also collected from animals at 28 days postinfection. Viral titers
in the tissue homogenates were determined by standard plaque assays in
NIH 3T3 cells. The limit of detection was 10 PFU/ml of the tissue
homogenate. The values shown represent averages from triplicate
experiments; the error bars indicate standard deviations. Error bars
that are not evident indicate that the standard deviation was less than
or equal to the height of the symbols. WT, wild type.
|
|
Characterization of virulence of the viruses in immunodeficient
mice.
It has been shown that immunodeficient animals are extremely
susceptible to MCMV infection (19, 34, 36, 38). For example, CB17 SCID mice, which lacks functional T and B lymphocytes, are extremely sensitive to viral infection (as few as 10 PFU of MCMV could
cause serious infection) (34, 36). Analysis of viral pathogenesis in these mice therefore serves as an excellent model for
determining the virulence of different MCMV strains and mutants and
studying the mechanism of how they cause opportunistic infections in
immunocompromised hosts. To determine whether the M37 open reading
frame plays a significant role in CMV virulence, we compared the
survival rates of animals infected with RvM37 and those of mice
infected with RqM37 and the wild-type Smith strain. For each virus,
five SCID mice were injected intraperitoneally with 104 PFU
of RvM37, RqM37, or the Smith strain. All mice infected with the
wild-type virus or RqM37 died within 23 to 26 days postinfection, whereas none of the RvM37-infected mice had died by 50 days
postinfection (Fig. 5). Indeed, no
RvM37-infected animals had died by 120 days postinfection, at which
time the experiments were terminated because some of the mock-infected
mice succumbed to unrelated opportunistic infections (data not shown).
This observation indicated that RvM37 is avirulent in SCID mice. It has
recently been demonstrated in our laboratory that the presence of the
transposon sequence per se within the viral genome does not
significantly affect MCMV virulence in SCID mice (54). Thus,
these results suggest that disruption of the M37 open reading frame
abolishes viral virulence and that M37 may be essential for MCMV
virulence in SCID mice.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 5.
Mortality of SCID mice infected with the Smith strain
(wild type [WT]), RvM37, and RqM37. CB17 SCID mice (five animals per
group) were infected intraperitoneally with 104 PFU of each
virus. Mortality was monitored for at least 120 days postinfection, and
survival rates were determined.
|
|
Characterization of growth of the viruses in immunodeficient
mice.
To further study the pathogenesis of the mutant virus in
SCID mice, replication of RvM37 in different organs of the mice was studied during a 21-day infection period before mortality of the animals infected with the Smith strain and RqM37 became apparent. In
these experiments, SCID mice were injected intraperitoneally with
104 PFU of each virus. At 1, 3, 7, 10, 14, and 21 days
postinfection, we sacrificed three mice from each virus group and
harvested the salivary glands, lungs, spleens, livers, and kidneys. The
viral titers in these five organs were determined. At 21 days
postinfection, titers of the Smith strain and rescued virus RqM37 in
the salivary glands, lungs, spleens, livers, and kidneys were about
5 × 105, 2 × 105, 5 × 104, 5 × 103, and 1 × 104 PFU/ml of organ homogenate, respectively; in contrast,
titers of RvM37 in the salivary glands, lungs, spleens, and kidneys
were less than 2 × 101 PFU/ml of organ homogenate,
while RvM37 titers in the livers were less than 102 PFU/ml
of organ homogenate (Fig. 6). Therefore,
RvM37 appeared to be severely attenuated in growth in the organs from
immunodeficient animals. Previous studies have shown that the presence
of the transposon sequence per se within the viral genome does not
significantly affect viral growth in SCID mice in vivo (54).
Thus, these results suggest that the attenuated growth of RvM37 in
these organs is probably due to the disruption of M37 and that M37 is
essential for optimal growth of MCMV in these organs in immunodeficient hosts.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 6.
Titers of MCMV mutants in salivary glands, lungs,
spleens, livers, and kidneys of infected SCID mice. CB17 SCID mice were
infected intraperitoneally with 104 PFU of each virus. At
1, 3, 7, 10, 14, and 21 days postinfection, the animals (three mice per
group) were sacrificed. The salivary glands, lungs, spleens, livers,
and kidneys were collected and sonicated. Viral titers in the tissue
homogenates were determined by standard plaque assays in NIH 3T3 cells.
The limit of detection was 10 PFU/ml of the tissue homogenate. The
values shown represent averages obtained from triplicate experiments;
the error bars indicate standard deviations. Error bars that are not
evident indicate that the standard deviation was less than or equal to
the height of the symbols. WT, wild type.
|
|
Characterization of genomic stability of the viral mutant after
replication in vivo.
Our previous studies indicated that a
transposon sequence inserted at several regions (e.g., m09, M25, and
M83) of the MCMV genome is stable during viral replication in NIH 3T3
cells and in both BALB/c and SCID mice (53, 54). However, it
is not known whether the transposon sequence inserted at the M37 region is stable. It has been shown that viral mutants with an additional insertion sequence are not stable and generate spontaneous mutations during replication in vitro and in vivo (2, 29; X. Zhan, M. Lee, G. Abenes, and F. Liu, unpublished results). It is
possible that the transposon sequence in RvM37 is not stable during
viral replication in vivo, and the introduction of an adventitious
mutation may be responsible for the observed phenotypes of the virus in animals. To investigate whether the genome of RvM37 is stable during
replication in vivo, the viruses were recovered from salivary glands of
the RvM37-infected BALB/c mice as well as livers of the RvM37-infected
SCID mice at 21 days postinfection. Viruses were also recovered from
the lungs of infected BALB/c mice at 10 days postinfection. Viral DNAs
were purified, and their restriction digestion patterns were analyzed
in agarose gels. Figure 7 shows a
Southern analysis of the RvM37 viral DNAs isolated from the salivary
glands and lungs of the infected BALB/c mice with a DNA probe that
contained the transposon and M37 sequence. These results indicated that
no change in the hybridization patterns of RvM37 occurred as a result
of viral growth in the animals for either 10 or 21 days (lanes 2 to 4).
Moreover, the overall EcoRI digestion patterns of RvM37 DNA
isolated from either infected cultured cells or animals were identical
to those of the original recombinant virus RvM37, as visualized by
ethidium bromide staining of the viral DNAs (data not shown). Similar
results were observed for viruses isolated from livers of the infected
SCID mice (data not shown). Thus, the transposon insertion in RvM37
appeared to be stable, and the genome of RvM37 remained intact during
replication in the animals.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 7.
Stability of the transposon mutation of RvM37 in BALB/c
mice. Viral DNAs were isolated either from cells that were infected
with RvM37 (MOI < 0.01) and allowed to grow in culture for 5 days
(P0; lane 2) or from cells that were infected with the virus collected
from the salivary glands (SG; lanes 3) or lungs (LU; lane 4) of BALB/c
mice 10 (lane 4) or 21 (lane 3) days after intraperitoneal inoculation
with 104 PFU of RvM37. Southern analyses of the viral DNA
fractions digested with EcoRI are shown. DNA of the
wild-type virus (WT) is shown in lane 1. The
32P-radiolabeled probe was derived from the same plasmid
which was used for Southern analyses of RvM37 in Fig. 1 and contained
the transposon and the M37 open reading frame sequence.
|
|
 |
DISCUSSION |
In this study, we have characterized an MCMV mutant that contained
a transposon insertional mutation in open reading frame M37. Our
results provide the first direct evidence to suggest that M37 is not
essential for viral replication in vitro in NIH 3T3 cells. Moreover,
disruption of the M37 open reading frame results in severely reduced
growth of the virus in both immunocompetent and immunodeficient hosts
and abolishes viral virulence in killing SCID mice. These observations
strongly suggest that M37 probably encodes a virulence factor and is
required for MCMV virulence in killing SCID mice and for optimal viral
growth in vivo.
While it is possible that the functional protein product might be
synthesized from the transposon-disrupted region, the results presented
here suggest that this may not be the case. First, the transposon
sequence was inserted into the 5' region of the M37 coding sequence
(Fig. 1B). Second, the transcription from the region downstream from
the transposon insertion site was not detected in cells infected with
the mutant virus (Fig. 2). Thus, the region of the target open reading
frame downstream from the transposon insertion site, which includes
about 65% of the M37 coding sequence, was not expressed. Therefore, it
is likely that no functional M37 protein was expressed from the viral
mutant. Our results indicate that the growth rate of RvM37 in NIH 3T3
cells was not significantly different from that of the Smith strain.
These observations suggest that M37, or at least the carboxyl-terminal
sequence of the open reading frame, is not essential for viral
replication in NIH 3T3 cells.
Our results indicate that RvM37 replicated poorly in the salivary
glands, lungs, spleens, livers, and kidneys of both BALB/c and SCID
mice that were intraperitoneally infected. For example, at 21 days
postinfection, the titers of RvM37 in the salivary glands, lungs,
spleens, and kidneys of the SCID mice were less than 2 × 101 PFU/ml of organ homogenate, while the RvM37 titers in
the livers were less than 102 PFU/ml of organ homogenate.
In contrast, titers of the Smith strain as well as of rescued virus
RqM37 in the salivary glands, lungs, spleens, livers, and kidneys of
the infected animals were about 5 × 105, 2 × 105, 5 × 104, 5 × 103,
and 1 × 104 PFU/ml of organ homogenate, respectively
(Fig. 6). Moreover, all SCID mice infected with RvM37 survived up to
120 days postinfection, while all mice infected with the Smith strain
or RqM37 died within 26 days postinfection (Fig. 5). These results
strongly suggest that M37 is a determinant for MCMV growth in vivo in
these animals and for virulence in SCID mice.
It is possible that the observed change in the levels of virulence and
growth of the mutant in animals is due to other adventitious mutations
introduced during the construction and growth of the recombinant virus
in cultured cells or in animals. However, several lines of evidence
strongly suggest that this is unlikely. First, the wild-type phenotypes
for growth in both BALB/c and SCID mice and virulence in SCID mice were
restored in RqM37 upon restoration of the wild-type sequence in RvM37
(Fig. 1, 4, 5, and 6). Furthermore, restoration of the wild-type
phenotypes in RqM37 occurred together with the restoration of M37
expression (Fig. 2). These observations suggest that the transposon
insertion rather than an adventitious mutation is responsible for the
observed attenuation of RvM37 replication and virulence in BALB/c and
SCID mice. Second, our previous studies indicated that a virus mutant
(i.e., Rvm09) with transposon insertion at the m09 open reading frame
replicated as well as the wild-type virus in both BALB/c and SCID mice
(54). Moreover, mutant Rvm09 exhibited a similar level of
lethality in SCID mice as the wild-type virus. These observations
indicated that the transposon sequence per se in the viral genome does
not significantly affect viral replication and virulence in these animals (54). Third, the genome and the transposon insertion in the viral mutant were stable during replication in animals. There
was no change in the hybridization patterns of the DNAs from the mutant
viruses that were recovered from various organs of the infected animals
after either 10 or 21 days of infection (Fig. 7 and data not shown).
Moreover, the EcoRI digestion patterns of the RvM37 mutant
DNAs, other than the transposon insertion region, appeared to be
identical to those of the wild-type virus DNA (data not shown). Thus,
the observed change in the level of RvM37 replication and virulence in
the infected animals is probably due to the disruption of M37
expression as a result of the transposon insertion.
The function of M37 is not known. Indeed, to our knowledge, neither the
transcript nor the protein product encoded by this open reading frame
has been reported. Our results indicate that a transcript of about
4,000 nucleotides is expressed from the M37 open reading frame. UL37,
the HCMV counterpart of M37, encodes at least three immediate-early
glycoproteins, UL37x1, gpUL37, and UL37m (9, 17). These
three proteins share the amino-terminal sequence because of alternative
splicing and polyadenylylation of transcripts initiating at the same
promoter and have been shown to be localized in the mitochondria as
well as in the plasma membrane (9, 11, 17). The UL37-encoded
proteins have been shown to transactivate selectively genes under
control of both cellular and HCMV promoters and, more recently, have
also been found to have antiapoptotic activities (10, 12,
17). It appears that the hydrophobic leader sequence and the
acidic domain, both located within the first 120 amino acids at the
amino terminus of these proteins, are responsible for the antiapoptotic
and transcription regulation activities, respectively (10, 12,
17). Indeed, an HCMV mutant with a deletion of the exon 3 region
of gpUL37 grows as well as the wild-type virus in human cultured cells, suggesting that the carboxyl-terminal region of UL37 is not essential for HCMV replication in vitro (3). Meanwhile, previous
studies suggest that transcripts from the UL36-UL38 region may be
essential for viral replication in vitro (35, 44). Thus,
whether the amino-terminal region of UL37 is essential for HCMV
replication in vitro is still not clear. Meanwhile, the functions of
UL37 in HCMV pathogenesis and virulence in vivo are not known. Our results provide the first direct evidence to suggest that M37 is
probably required for optimal viral growth in vivo in both immunocompetent and immunodeficient hosts and is essential for virulence in SCID mice. It will be interesting to determine whether M37, like UL37, also possesses transactivation and antiapoptotic activities. Extensive homology in amino acid sequence between M37 and
UL37 was found at the carboxyl-terminal region (7, 37).
However, very limited sequence homology was found between the
amino-terminal sequences of these two open reading frames (7,
37; M. Lee, A. McGregor, and F. Liu, unpublished results). These observations raise the possibility that the carboxyl-terminal regions of these open reading frames may be important for CMV pathogenesis. Further studies will reveal how M37 functions as a viral
virulence factor and may provide insight into the function of UL37 in
HCMV pathogenesis and virulence in humans. Meanwhile, further studies
are needed to investigate whether UL37 is functionally equivalent to M37.
Previous studies have shown that MCMV mutants with deletion of a
cluster of at least three open reading frames (e.g., m139, m140, and
m141) are avirulent in killing SCID mice (6, 20). The
results reported in this study, to our knowledge, demonstrate for the
first time that disruption of a single MCMV open reading frame leads to
complete abolishment of viral virulence in SCID mice. A key question
from our results is how the lack of M37 leads to a change in the level
of virulence and growth. It is possible that the defect of M37 inhibits
the spread of the virus to the target organs, entry into permissive
cells, or full replication inside infected cells. Given that UL37
possesses transactivation and antiapoptotic activities (12,
17), it is conceivable that a viral mutant with disruption of
M37, while replicating normally in NIH 3T3 fibroblasts, exhibits a
defect in certain steps of viral replication, such as viral gene
expression, in vivo in particular organs or tissues. This defect may
lead to slow growth of the viral mutant in the organs and consequently
contribute to severe reduction of growth of the viral mutant in vivo.
Alternatively, M37 may be involved in virus-host interactions and play
an important role in modulating the host cells for optimal viral
replication. Further studies on in vitro and in vivo replication of
RvM37 and other viral mutants will provide further insight into the
functions of viral genes in vivo in MCMV virulence and pathogenesis.
 |
ACKNOWLEDGMENTS |
We thank Edward Mocarski, Stanford University, for helpful advice
and Michael Snyder, Yale University, for providing the Tn3 transposon constructs and the E. coli strains for transposon
shuttle mutagenesis. Gratitude also goes to John Kim and Ada Tam for
excellent technical assistance.
M.L. is a recipient of a predoctoral dissertation fellowship of the
State of California AIDS Research Program (D00-B-105). E.H.
acknowledges fellowship support from the UC-Berkeley Biology Fellow
program. W.D. is partially supported by a block grant predoctoral fellowship from the Graduate Division of the University of
California
Berkeley. F.L. is a Pew Scholar in Biomedical Sciences and
a recipient of a Basil O'Connor Starter Scholar Research Award (March
of Dimes National Birth Defects Foundation) and a Regents Junior
Faculty Fellowship (University of California). This research was
supported in part by a Chancellor's Special Initiative Grant Award
from UC-Berkeley and a grant from the State of California AIDS Research Program.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Program in
Infectious Diseases and Immunity, School of Public Health, 140 Warren
Hall, University of California, Berkeley, CA 94720. Phone: (510)
643-2436. Fax: (510) 642-6350. E-mail:
liu_fy{at}uclink4.berkeley.edu.
 |
REFERENCES |
| 1.
|
Al-Barazi, H. O., and A. M. Colberg-Poley.
1996.
The human cytomegalovirus UL37 immediate-early regulatory protein is an integral membrane N-glycoprotein which traffics through the endoplasmic reticulum and Golgi apparatus.
J. Virol.
70:7198-7208[Abstract/Free Full Text].
|
| 2.
|
Boname, J. M., and J. K. Chantler.
1992.
Characterization of a strain of murine cytomegalovirus which fails to grow in the salivary glands of mice.
J. Gen. Virol.
73:2021-2029[Abstract/Free Full Text].
|
| 3.
|
Borst, E.,
G. Hahn,
U. H. Koszinowski, and M. Messerle.
1999.
Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial chromosome in Escherichia coli: a new approach for construction of HCMV mutants.
J. Virol.
73:8320-8329[Abstract/Free Full Text].
|
| 4.
|
Britt, W. J., and C. A. Alford.
1996.
Cytomegalovirus, p. 2493-2523.
In
B. N. Fields, D. M. Knipe, et al. (ed.), Virology, 3rd ed. Raven Press, New York, N.Y.
|
| 5.
|
Brune, W.,
C. Menard,
U. Hobom,
S. Odenbreit,
M. Messerle, and U. H. Koszinowski.
1999.
Rapid identification of essential and nonessential herpesvirus genes by direct transposon mutagenesis.
Nat. Biotechnol.
17:360-364[CrossRef][Medline].
|
| 6.
|
Cavanaugh, V. J.,
R. M. Stenberg,
T. L. Staley,
H. W. Virgin III,
M. R. MacDonald,
S. Paetzold,
H. E. Farrell,
W. D. Rawlinson, and A. E. Campbell.
1996.
Murine cytomegalovirus with a deletion of genes spanning HindIII-J and -I displays altered cell and tissue tropism.
J. Virol.
70:1365-1374[Abstract].
|
| 7.
|
Chee, M. S.,
A. T. Bankier,
S. Beck,
R. Bohni,
C. M. Brown,
R. Cerny,
T. Horsnell,
C. A. Hutchison,
T. Kouzarides, and J. A. Martignetti.
1990.
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.
Curr. Top. Microbiol. Immunol.
154:125-169[Medline].
|
| 8.
|
Cohen, J. I., and K. E. Seidel.
1993.
Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro.
Proc. Natl. Acad. Sci. USA
90:7376-7380[Abstract/Free Full Text].
|
| 9.
|
Colberg-Poley, A. M.
1996.
Functional roles of immediate early proteins encoded by the human cytomegalovirus UL36-38, UL115-119, TRS1/IRS1 and US3 loci.
Intervirology
39:350-360[Medline].
|
| 10.
|
Colberg-Poley, A. M.,
L. Huang,
V. E. Soltero,
A. C. Iskenderian,
R. F. Schumacher, and D. G. Anders.
1998.
The acidic domain of pUL37x1 and gpUL37 plays a key role in transactivation of HCMV DNA replication gene promoter constructions.
Virology
246:400-408[CrossRef][Medline].
|
| 11.
|
Colberg-Poley, A. M.,
M. B. Patel,
D. P. Erezo, and J. E. Slater.
2000.
Human cytomegalovirus UL37 immediate-early regulatory proteins traffic through the secretory apparatus and to mitochondria.
J. Gen. Virol.
81:1779-1789[Abstract/Free Full Text].
|
| 12.
|
Colberg-Poley, A. M.,
L. D. Santomenna,
P. P. Harlow,
P. A. Benfield, and D. J. Tenney.
1992.
Human cytomegalovirus US3 and UL36-38 immediate-early proteins regulate gene expression.
J. Virol.
66:95-105[Abstract/Free Full Text].
|
| 13.
|
Cunningham, C., and A. J. Davison.
1993.
A cosmid-based system for constructing mutants of herpes simplex virus type 1.
Virology
197:116-124[CrossRef][Medline].
|
| 14.
|
Dallas, P. B.,
P. A. Lyons,
J. B. Hudson,
A. A. Scalzo, and G. R. Shellam.
1994.
Identification and characterization of a murine cytomegalovirus gene with homology to the UL25 open reading frame of human cytomegalovirus.
Virology
200:643-650[CrossRef][Medline].
|
| 15.
|
Delecluse, H. J.,
T. Hilsendegen,
D. Pich,
R. Zeidler, and W. Hammerschmidt.
1998.
Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells.
Proc. Natl. Acad. Sci. USA
95:8245-8250[Abstract/Free Full Text].
|
| 16.
|
Fleming, P.,
N. Davis-Poynter,
M. Degli-Esposti,
E. Densley,
J. Papadimitriou,
G. Shellam, and H. Farrell.
1999.
The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity.
J. Virol.
73:6800-6809[Abstract/Free Full Text].
|
| 17.
|
Goldmacher, V. S.,
L. M. Bartle,
A. Skaletskaya,
C. A. Dionne,
N. L. Kedersha,
C. A. Vater,
J. Han,
R. J. Lutz,
S. Watanabe,
E. D. McFarland,
E. D. Kieff,
E. S. Mocarski, and T. Chittenden.
1999.
A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2.
Proc. Natl. Acad. Sci. USA
96:12536-12541[Abstract/Free Full Text].
|
| 18.
|
Greaves, R. F.,
J. M. Brown,
J. Vieira, and E. S. Mocarski.
1995.
Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene.
J. Gen. Virol.
76:2151-2160[Abstract/Free Full Text].
|
| 19.
|
Grundy, J. E., and C. J. Melief.
1982.
Effect of Nu/Nu gene on genetically determined resistance to murine cytomegalovirus.
J. Gen. Virol.
61:133-136[Abstract/Free Full Text].
|
| 20.
|
Hanson, L. K.,
J. S. Slater,
Z. Karabekian,
H. W. Virgin III,
C. A. Biron,
M. C. Ruzek,
N. van Rooijen,
R. P. Ciavarra,
R. M. Stenberg, and A. E. Campbell.
1999.
Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis.
J. Virol.
73:5970-5980[Abstract/Free Full Text].
|
| 21.
|
Hudson, J. B.
1979.
The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections.
Arch. Virol.
62:1-29[CrossRef][Medline].
|
| 22.
|
Jenkins, F. J.,
M. J. Casadaban, and B. Roizman.
1985.
Application of the mini-Mu-phage for target-sequence-specific insertional mutagenesis of the herpes simplex virus genome.
Proc. Natl. Acad. Sci. USA
82:4773-4777[Abstract/Free Full Text].
|
| 23.
|
Jones, T. R., and L. Sun.
1997.
Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains.
J. Virol.
71:2970-2979[Abstract].
|
| 24.
|
Jordan, M. C.
1983.
Latent infection and the elusive cytomegalovirus.
Rev. Infect. Dis.
5:205-215[Medline].
|
| 25.
|
Kemble, G.,
G. Duke,
R. Winter, and R. Spaete.
1996.
Defined large-scale alterations of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids.
J. Virol.
70:2044-2048[Abstract].
|
| 26.
|
Liu, F., and B. Roizman.
1991.
The herpes simplex virus 1 gene encoding a protease also contains within its coding domain the gene encoding the more abundant substrate.
J. Virol.
65:5149-5156[Abstract/Free Full Text].
|
| 27.
|
MacDonald, M. R.,
M. W. Burney,
S. B. Resnick, and H. W. Virgin, III.
1999.
Spliced mRNA encoding the murine cytomegalovirus chemokine homolog predicts a beta chemokine of novel structure.
J. Virol.
73:3682-3691[Abstract/Free Full Text].
|
| 28.
|
MacDonald, M. R.,
X. Y. Li, and H. W. Virgin, III.
1997.
Late expression of a beta chemokine homolog by murine cytomegalovirus.
J. Virol.
71:1671-1678[Abstract].
|
| 29.
|
Manning, W. C.,
C. A. Stoddart,
L. A. Lagenaur,
G. B. Abenes, and E. S. Mocarski.
1992.
Cytomegalovirus determinant of replication in salivary glands.
J. Virol.
66:3794-3802[Abstract/Free Full Text].
|
| 30.
|
McGeoch, D. J.
1989.
The genomes of the human herpesviruses: contents, relationships, and evolution.
Annu. Rev. Microbiol.
43:235-265[CrossRef][Medline].
|
| 31.
|
Messerle, M.,
I. Crnkovic,
W. Hammerschmidt,
H. Ziegler, and U. H. Koszinowski.
1997.
Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome.
Proc. Natl. Acad. Sci. USA
94:14759-14763[Abstract/Free Full Text].
|
| 32.
|
Mocarski, E. S.
1996.
Cytomegaloviruses and their replication, p. 2447-2492.
In
B. N. Fields, D. M. Knipe, et al. (ed.), Virology, 3rd ed. Raven Press, New York, N.Y.
|
| 33.
|
Mulligan, R. C., and P. Berg.
1981.
Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase.
Proc. Natl. Acad. Sci. USA
78:2072-2076[Abstract/Free Full Text].
|
| 34.
|
Okada, M., and Y. Minamishima.
1987.
The efficacy of biological response modifiers against murine cytomegalovirus infection in normal and immunodeficient mice.
Microbiol. Immunol.
31:45-57[Medline].
|
| 35.
|
Pari, G. S.,
A. K. Field, and J. A. Smith.
1995.
Potent antiviral activity of an antisense oligonucleotide complementary to the intron-exon boundary of human cytomegalovirus genes UL36 and UL37.
Antimicrob. Agents Chemother.
39:1157-1161[Abstract].
|
| 36.
|
Pollock, J. L., and H. W. Virgin, III.
1995.
Latency, without persistence, of murine cytomegalovirus in the spleen and kidney.
J. Virol.
69:1762-1768[Abstract].
|
| 37.
|
Rawlinson, W. D.,
H. E. Farrell, and B. G. Barrell.
1996.
Analysis of the complete DNA sequence of murine cytomegalovirus.
J. Virol.
70:8833-8849[Abstract].
|
| 38.
|
Reynolds, R. P.,
R. J. Rahija,
D. I. Schenkman, and C. B. Richter.
1993.
Experimental murine cytomegalovirus infection in severe combined immunodeficient mice.
Lab. Anim. Sci.
43:291-295[Medline].
|
| 39.
|
Roizman, B., and A. E. Sears.
1996.
Herpes simplex viruses and their replication, p. 2231-2296.
In
B. N. Fields, D. M. Knipe, et al. (ed.), Virology, 3rd ed. Raven Press, New York, N.Y.
|
| 40.
|
Saederup, N.,
Y. C. Lin,
D. J. Dairaghi,
T. J. Schall, and E. S. Mocarski.
1999.
Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host.
Proc. Natl. Acad. Sci. USA
96:10881-10886[Abstract/Free Full Text].
|
| 41.
|
Saeki, Y.,
T. Ichikawa,
A. Saeki,
E. A. Chiocca,
K. Tobler,
M. Ackermann,
X. O. Breakefield, and C. Fraefel.
1998.
Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors.
Hum. Gene Ther.
9:2787-2794[Medline].
|
| 42.
|
Smith, G. A., and L. W. Enquist.
1999.
Construction and transposon mutagenesis in Escherichia coli of a full-length infectious clone of pseudorabies virus, an alphaherpesvirus.
J. Virol.
73:6405-6414[Abstract/Free Full Text].
|
| 43.
|
Smith, G. A., and L. W. Enquist.
2000.
A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis.
Proc. Natl. Acad. Sci. USA
97:4873-4878[Abstract/Free Full Text].
|
| 44.
|
Smith, J. A., and G. S. Pari.
1995.
Expression of human cytomegalovirus UL36 and UL37 genes is required for viral DNA replication.
J. Virol.
69:1925-1231[Abstract].
|
| 45.
|
Stavropoulos, T. A., and C. A. Strathdee.
1998.
An enhanced packaging system for helper-dependent herpes simplex virus vectors.
J. Virol.
72:7137-7143[Abstract/Free Full Text].
|
| 46.
|
Tomazin, R.,
J. Boname,
N. R. Hegde,
D. M. Lewinsohn,
Y. Altschuler,
T. R. Jones,
P. Cresswell,
J. A. Nelson,
S. R. Riddell, and D. C. Johnson.
1999.
Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells.
Nat. Med.
5:1039-1043[CrossRef][Medline].
|
| 47.
|
Tomkinson, B.,
E. Robertson,
R. Yalamanchili,
R. Longnecker, and E. Kieff.
1993.
Epstein-Barr virus recombinants from overlapping cosmid fragments.
J. Virol.
67:7298-7306[Abstract/Free Full Text].
|
| 48.
|
van Zijl, M.,
W. Quint,
J. Briaire,
T. de Rover,
A. Gielkens, and A. Berns.
1988.
Regeneration of herpesviruses from molecularly cloned subgenomic fragments.
J. Virol.
62:2191-2195[Abstract/Free Full Text].
|
| 49.
|
Vieira, J.,
H. E. Farrell,
W. D. Rawlinson, and E. S. Mocarski.
1994.
Genes in the HindIII J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: insertion mutagenesis with a lacZ/gpt cassette.
J. Virol.
68:4837-4846[Abstract/Free Full Text].
|
| 50.
|
Wagner, M.,
S. Jonjic,
U. H. Koszinowski, and M. Messerle.
1999.
Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution.
J. Virol.
73:7056-7060[Abstract/Free Full Text].
|
| 51.
|
Weber, P. C.,
M. Levine, and J. C. Glorioso.
1987.
Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis.
Science
236:576-579[Abstract/Free Full Text].
|
| 52.
|
Wu, C. A.,
M. E. Carlson,
S. C. Henry, and J. D. Shanley.
1999.
The murine cytomegalovirus M25 open reading frame encodes a component of the tegument.
Virology
262:265-276[CrossRef][Medline].
|
| 53.
|
Zhan, X.,
M. Lee,
G. Abenes,
I. VonReis,
C. Kittinunvorakoon,
P. Ross-Macdonald,
M. Snyder, and F. Liu.
2000.
Mutagenesis of murine cytomegalovirus using a Tn3-based transposon.
Virology
266:264-274[CrossRef][Medline].
|
| 54.
|
Zhan, X.,
M. Lee,
J. Xiao, and F. Liu.
2000.
Construction and characterization of murine cytomegaloviruses that contain a transposon insertion at open reading frames m09 and M83.
J. Virol.
74:7411-7421[Abstract/Free Full Text].
|
Journal of Virology, December 2000, p. 11099-11107, Vol. 74, No. 23
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Jurak, I., Schumacher, U., Simic, H., Voigt, S., Brune, W.
(2008). Murine Cytomegalovirus m38.5 Protein Inhibits Bax-Mediated Cell Death. J. Virol.
82: 4812-4822
[Abstract]
[Full Text]
-
Adair, R., Liebisch, G. W., Su, Y., Colberg-Poley, A. M.
(2004). Alteration of cellular RNA splicing and polyadenylation machineries during productive human cytomegalovirus infection. J. Gen. Virol.
85: 3541-3553
[Abstract]
[Full Text]
-
Mavinakere, M. S., Colberg-Poley, A. M.
(2004). Internal cleavage of the human cytomegalovirus UL37 immediate-early glycoprotein and divergent trafficking of its proteolytic fragments. J. Gen. Virol.
85: 1989-1994
[Abstract]
[Full Text]
-
Mavinakere, M. S., Colberg-Poley, A. M.
(2004). Dual targeting of the human cytomegalovirus UL37 exon 1 protein during permissive infection. J. Gen. Virol.
85: 323-329
[Abstract]
[Full Text]
-
Su, Y., Adair, R., Davis, C. N., DiFronzo, N. L., Colberg-Poley, A. M.
(2003). Convergence of RNA cis Elements and Cellular Polyadenylation Factors in the Regulation of Human Cytomegalovirus UL37 Exon 1 Unspliced RNA Production. J. Virol.
77: 12729-12741
[Abstract]
[Full Text]
-
Zhu, J., Chen, J., Hai, R., Tong, T., Xiao, J., Zhan, X., Lu, S., Liu, F.
(2003). In Vitro and In Vivo Characterization of a Murine Cytomegalovirus with a Mutation at Open Reading Frame m166. J. Virol.
77: 2882-2891
[Abstract]
[Full Text]
-
Su, Y., Testaverde, J. R., Davis, C. N., Hayajneh, W. A., Adair, R., Colberg-Poley, A. M.
(2003). Human cytomegalovirus UL37 immediate early target minigene RNAs are accurately spliced and polyadenylated. J. Gen. Virol.
84: 29-39
[Abstract]
[Full Text]
-
Hayajneh, W. A., Contopoulos-Ioannidis, D. G., Lesperance, M. M., Venegas, A. M., Colberg-Poley, A. M.
(2001). The carboxyl terminus of the human cytomegalovirus UL37 immediate-early glycoprotein is conserved in primary strains and is important for transactivation. J. Gen. Virol.
82: 1569-1579
[Abstract]
[Full Text]